WCN23-0601 MORTALITY OF PATIENTS WITH CKD AND ITs RISK FACTORS ADMITTED TO HOSPITAL WITH COVID-19 IN ALMATY CITY KAZAKHSTAN BETWEEN 2020-2022

Laura Garazhayeva, Abduzhappar Gaipov, Gulnur Zhakhina, V. Kim, A. Gusmanov, Yesbolat Sakko, Sauran Yerdessov, Dmitriy Syssoyev, Almagul Kauysheva

Kidney International Reports, 2023

Full text Open access: Gold Metadata (CSL-JSON)

DOI 10.1016/j.ekir.2023.02.1031

Data confidence 85 high

How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The global prevalence of chronic kidney disease (CKD) is approximately between 9 and 12%. One of the main predictors of CKD is elderly age, and about 38% of patients are older than 65 years of age. People with CKD have impairment of the normal reaction of the innate and adaptive immune systems. Therefore, this cohort of patients is more predisposed to chronic comorbid conditions and viral infections. The COVID-19 pandemic shifted the morbidity and mortality of people with CKD. The research shows that patients with kidney disease were more likely to have worse outcomes from coronavirus infection compared to patients without CKD.